drugset
drugset / Trial / NCT01318031

Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects

NCT01318031 ↗

Phase 1 Completed 14 enrolled Pfizer
Non-randomizedParallel-groupOpen-labelBasic science

Summary

Study of a drug drug interaction between Paroxetine and PF-00299804.

Timeline

Start
2011-03
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DACOMITINIB ANHYDROUS Small molecule 45 mg —
Subject Paroxetine Small molecule 30 mg —

Indications

No indication recorded.